| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.22B | +8.7% |
| Cost of Revenue | $2.62B | +9.6% |
| R&D Expense | $3.3M | +6.5% |
| SG&A Expense | $358.6M | +10.0% |
| Operating Income | $53.5M | -42.3% |
| Interest Expense | $48.4M | -18.8% |
| Pre-tax Income | $17.7M | -62.3% |
| Income Tax | $8.4M | -11.6% |
| Net Income | $9.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.2M | -86.0% |
| Accounts Receivable | $372.6M | +2.9% |
| Inventory | $260.7M | +15.3% |
| Current Assets | $704.5M | -12.9% |
| Total Assets | $1.70B | -10.0% |
| Current Liabilities | $795.4M | -16.9% |
| Long-term Debt | $567.8M | -29.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $154.6M | +13.3% |
| Capital Expenditures | $60.3M | +20.6% |
| Investing Cash Flow | -$60.5M | -146.8% |
| Financing Cash Flow | -$248.7M | -76.5% |
| Free Cash Flow | $94.3M | +9.0% |
| -75.4% |
| EPS (Basic) | $0.18 | -75.7% |
| EPS (Diluted) | $0.18 | -74.6% |
| Total Liabilities |
| $1.53B |
| -12.8% |
| Stockholders' Equity | $172.9M | +26.4% |